Gene · 774
Papers1,947
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,947
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Lung Cancer Stem Cells with Trimebutine: Synergistic Antitumor Activity in Combination with Cisplatin. | Int J Mol Sci | 2026 | 42794641 | PubTator, text mining | PubMed |
| Macro-Micro structural integration for characterizing severity-related structural alterations in mild cognitive impairment. | Neuroimage Clin | 2026 | 42771911 | PubTator, text mining | PubMed |
| Correction to "The Transmitter Release-Site CaV2.2 Channel Cluster is Linked to an Endocytosis Coat Protein Complex". | Eur J Neurosci | 2026 | 42689417 | PubTator, text mining | PubMed |
| Structural rigidity of the I-II loop couples CaV β anchoring to CaV2.2 gating modes. | Proc Natl Acad Sci U S A | 2026 | 42485390 | PubTator, text mining | PubMed |
| A human-derived Pseudorabies virus isolate induces Cav2.2-sensitive Ca2+ influx and JNK-associated retinal epithelial injury. | Microbiol Spectr | 2026 | 42461027 | PubTator, text mining | PubMed |
| Synaptic Ca2+ channels and neurexins are linked through direct and indirect binding complexes. | Sci Rep | 2026 | 42457853 | PubTator, text mining | PubMed |
| Pharmacological Inhibition of Cav2.2 Channels by Recombinant Phα1β Toxin (CTK01512-2). | Basic Clin Pharmacol Toxicol | 2026 | 42383434 | PubTator, text mining | PubMed |
| Targeting Cav2.2 channels for pain management: challenges, innovations, and future perspectives. | Biochem Pharmacol | 2026 | 42361918 | PubTator, text mining | PubMed |
| Disruption of dopamine transmission by cholesterol depletion is associated with alterations in protein lipid raft partitioning and actin dynamics. | Neuropharmacology | 2026 | 42288194 | PubTator, text mining | PubMed |
| Nociceptor-enriched CAPS1 isoform couples to CaV2.2 channels and underlies inflammatory pain hypersensitivity. | bioRxiv | 2026 | 42244681 | PubTator, text mining | PubMed |
| Reduction of CACNA1D-Associated Catatonia Symptoms in an Adolescent With Concurrent Severe Autism Spectrum Disorder: A Case Report. | J ECT | 2026 | 42218824 | PubTator, text mining | PubMed |
| Physiological super-resolution in situ recording reveals kinetic changes of sympathetic norepinephrine release in heart failure. | Proc Natl Acad Sci U S A | 2026 | 42044334 | PubTator, text mining | PubMed |
| Early-life maternal care is required for the typical development of calming responses to back stroking. | Commun Biol | 2026 | 41963499 | PubTator, text mining | PubMed |
| Identification of a Calcium-Related Prognostic Signature and Validation of CACNA1B as a Driver of Metastasis in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2026 | 41909196 | PubTator, text mining | PubMed |
| FTO-CHRM3 axis regulates multiple myeloma progression: a machine learning-based identification. | Ann Hematol | 2026 | 41870649 | PubTator, text mining | PubMed |
| L-type calcium channel-mediated lipid metabolic reprogramming in gastric adenocarcinoma progression. | Transl Oncol | 2026 | 41861661 | PubTator, text mining | PubMed |
| α-Synuclein oligomers slow down action potential firing and enhance dopamine release by increasing Cav2.2 currents in midbrain dopaminergic neurons. | J Physiol | 2026 | 41837580 | PubTator, text mining | PubMed |
| Temporal lobe epilepsy is associated with neuroinflammation, extracellular matrix remodeling, and synaptic protein alterations. | Front Mol Neurosci | 2026 | 41800185 | PubTator, text mining | PubMed |
| Advances in calcium signalling research for the diagnosis and treatment of depression. | Ann Med | 2026 | 41787814 | PubTator, text mining | PubMed |
| Genome-Wide Association Study of Gross Hair Weight and Hair Length Traits in Different Body Regions of Tianzhu White Yak. | Biomolecules | 2026 | 41750351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/774/papers